Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RGDX > SEC Filings for RGDX > Form 8-K on 26-Aug-2013All Recent SEC Filings

Show all filings for RESPONSE GENETICS INC



Entry into a Material Definitive Agreement, Completion of Acquisition or Di

Item 1.01 Entry into a Material Definitive Agreement.

On August 23, 2013, Response Genetics, Inc. (the "Company") entered into an asset purchase agreement (the "Purchase Agreement") with Pathwork (assignment for the benefit of creditors), LLC ("Seller"), pursuant to which the Company acquired substantially all of the assets (the "Purchased Assets") of Pathwork Diagnostics, Inc. ("Pathwork"), which had previously assigned all of its assets to Seller for the benefit of its creditors pursuant to a General Assignment, dated as of April 2, 2013. Pursuant to the Purchase Agreement, the Company acquired all intellectual property, know-how, data, equipment and materials formerly owned by Pathwork which relate to its FDA-cleared Tissue of Origin ("TOO") test.

The Company acquired the assets for the following consideration: (i) 500,000 newly-issued registered shares of the Company's common stock (the "Shares") issued to two senior secured creditors (the "Senior Secured Creditors") of Pathwork which were designated by Seller in the Purchase Agreement and (ii) a cash payment of $200,000 to Seller.

The shares of the Company's common stock issued pursuant to the Purchase Agreement are fully registered and freely tradable, provided, however, that each of the Senior Secured Creditors has agreed to, except as may be required by law, not sell any of the Shares acquired by it prior to June 30, 2014 (the "Lockup Period") and not sell more than its pro rata share of an aggregate of 50,000 shares per month after the expiration of the Lockup Period.

A copy of the Purchase Agreement is attached hereto as Exhibit 10.1 and is incorporated herein by reference. The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of Exhibit 10.1 attached hereto.

Item 2.01 Completion of Acquisition or Disposition of Assets.

The information set forth in Item 1.01 of this Current Report on Form 8-K that relates to the acquisition of the Purchased Assets is incorporated by reference into this Item 2.01.

Item 8.01 Other Events.

On August 26, 2013, the Company issued a press release announcing the matters set forth in Item 1.01 of this Current Report on Form 8-K. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are being furnished with this Current Report on Form 8-K:

Exhibit Number Document Description

10.1 Asset Purchase Agreement, dated August 23, 2013, by and between Response Genetics, Inc. and Pathwork (assignment for the benefit of creditors), LLC.

99.1 Press Release, dated August 26, 2013.

  Add RGDX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RGDX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.